Limited specificity of serologic tests for SARS-CoV-2 antibody detection, Benin, Western Africa
Abstract
Testing 68 RT-PCR-confirmed COVID-19 cases and controls from Benin, Western Africa with commercially available SARS-CoV-2 antibody ELISAs revealed up to 25% false-positive results, likely due to unspecific antibody responses elicited by acute malaria. Serologic tests must be carefully evaluated to robustly assess SARS-CoV-2 spread and immunity in tropical regions.
Related articles
Related articles are currently not available for this article.